Induction Chemotherapy Reduces Patient-reported Toxicities During Neoadjuvant Chemoradiation with Intensity Modulated Radiotherapy for Rectal Cancer.

[1]  J. Guillem,et al.  Total neoadjuvant therapy for locally advanced rectal cancer. , 2017 .

[2]  G. Velikova,et al.  Systematic Review of Radiation Therapy Toxicity Reporting in Randomized Controlled Trials of Rectal Cancer: A Comparison of Patient-Reported Outcomes and Clinician Toxicity Reporting. , 2015, International journal of radiation oncology, biology, physics.

[3]  M. Fakih,et al.  The emerging role of neoadjuvant chemotherapy for rectal cancer. , 2014, Journal of gastrointestinal oncology.

[4]  Amy P Abernethy,et al.  Development of the National Cancer Institute's patient-reported outcomes version of the common terminology criteria for adverse events (PRO-CTCAE). , 2014, Journal of the National Cancer Institute.

[5]  N. Petrelli,et al.  Capecitabine and oxaliplatin in the preoperative multimodality treatment of rectal cancer: surgical end points from National Surgical Adjuvant Breast and Bowel Project trial R-04. , 2014, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[6]  K. Goodman,et al.  Neoadjuvant chemotherapy first, followed by chemoradiation and then surgery, in the management of locally advanced rectal cancer. , 2014, Journal of the National Comprehensive Cancer Network : JNCCN.

[7]  Satish S. C. Rao,et al.  Anorectal physiology and pathophysiology in the elderly. , 2014, Clinics in geriatric medicine.

[8]  T. Conroy,et al.  Clinical outcome of the ACCORD 12/0405 PRODIGE 2 randomized trial in rectal cancer. , 2012, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[9]  A. Bennett,et al.  Patient-Reported Outcomes vs. Clinician Symptom Reporting During Chemoradiation for Rectal Cancer. , 2012, Gastrointestinal cancer research : GCR.

[10]  D. Franchimont,et al.  Short course chemotherapy followed by concomitant chemoradiotherapy and surgery in locally advanced rectal cancer: a randomized multicentric phase II study. , 2012, Annals of oncology : official journal of the European Society for Medical Oncology.

[11]  W. Hohenberger,et al.  Induction Chemotherapy before Chemoradiotherapy and Surgery for Locally Advanced Rectal Cancer , 2010, Strahlentherapie und Onkologie.

[12]  Ronald C. Chen,et al.  Patient‐reported acute gastrointestinal symptoms during concurrent chemoradiation treatment for rectal cancer , 2010, Cancer.

[13]  S. Polo,et al.  Phase II, randomized study of concomitant chemoradiotherapy followed by surgery and adjuvant capecitabine plus oxaliplatin (CAPOX) compared with induction CAPOX followed by concomitant chemoradiotherapy and surgery in magnetic resonance imaging-defined, locally advanced rectal cancer: Grupo cancer d , 2010, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[14]  C. Pehl,et al.  Influence of Gender and Age on Anorectal Function: Normal Values from Anorectal Manometry in a Large Caucasian Population , 2010, Digestion.

[15]  Issam El Naqa,et al.  Elective clinical target volumes for conformal therapy in anorectal cancer: a radiation therapy oncology group consensus panel contouring atlas. , 2009, International journal of radiation oncology, biology, physics.

[16]  A. Norman,et al.  Neoadjuvant capecitabine and oxaliplatin followed by synchronous chemoradiation and total mesorectal excision in magnetic resonance imaging-defined poor-risk rectal cancer. , 2006, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[17]  C. Willett,et al.  Randomized phase II study of neoadjuvant combined-modality chemoradiation for distal rectal cancer: Radiation Therapy Oncology Group Trial 0012. , 2006, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[18]  Rainer Fietkau,et al.  Preoperative versus postoperative chemoradiotherapy for rectal cancer. , 2004, The New England journal of medicine.

[19]  Jack Clark,et al.  Symptom Indexes to Assess Outcomes of Treatment for Early Prostate Cancer , 2001, Medical care.